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Abstract 
Abnormal protease-resistant prion protein (PrP-res) is the only surrogate biochemical 
marker for prion diseases, and a sensitive technique to detect PrP-res in blood or tissues 
is urgently needed. Primary cultured bone marrow stromal cells (MSCs) expressed PrP 
and were capable of supporting stable human prion infection. Using a mouse-adapted 
BSE strain, we demonstrated that PrP-res can be detected in expanded MSCs. We then 
analyzed the bone marrow cells collected at autopsy from two individuals with sporadic 
Creutzfeldt-Jakob disease (CJD), and, in both cases, cultured MSCs were positive for 
PrP-res. These data would suggest that ex vivo MSC expansion accompanied by PrP-res 
analysis could be a helpful tool in the definitive diagnosis of prion disease at an earlier 
stage in the disease process than is currently possible, and with considerably less 
distress to the patient. (134 words) 
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Introduction 
Creutzfeldt-Jakob disease (CJD) in man is thought to be caused by an “infectious 
protein particle”, termed prion[1]. Accumulation of the disease-associated form of prion 
protein (PrPSc) and infectivity are seen mainly in the central nervous system (CNS), but 
are not limited to the CNS. Infectivity in the blood of sporadic CJD patients and 
experimentally infected animals has been reported[2], and recently it has been shown 
that variant CJD (vCJD) can be transmitted by transfusion[3,4]. The problem, however, 
is that detection of PrPSc in blood is extremely difficult and no reliable test exists[5]. 
For this reason, we instead focused on bone marrow stroma cells (MSCs)[6,7], which 
possess multipotential stem cell-like characteristics, and investigated whether or not 
they were susceptible to TSE agents. Ex vivo cultured MSCs expressed PrPC and were 
susceptible to a CJD agent. In addition, we were able to detect PrPSc in MSCs isolated 
from both infected animals and sporadic CJD patients. These results suggest that bone 
marrow biopsy followed by ex vivo expansion of MSCs could form the basis of a new 
diagnostic test for TSEs.  
Materials and Methods 
Isolation and culture of MSCs 
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Adult male Wistar rats, 8 weeks old, were killed and the femurs and tibias were 
dissected out. Isolation of the bone marrow was performed according to the method 
described by Azizi et al[7]. The ends of the bones were cut and the marrow was 
extruded with 5 ml of alpha-MEM (Sigma, St Louis, MO) supplemented with 10% fetal 
bovine serum (FBS), 100 µg/ml kanamycin, or 100 U/ml penicillin and 100µg /ml 
streptomycin. The bone marrow cells were incubated at 37 ºC with 95% humidity and 
5% CO2 for 48h, and the non-adherent cells removed by replacing the medium. 
Adherent cells were subcultured several times, and used for the transmission studies. 
The cells were subjected to a neuronal differentiation study to confirm that they were 
stromal cells (MSC), according to Dezawa’s method[8,9]. Additionally, bone marrow 
stromal cells isolated from mice, hamsters and cows were cultured in the same way as 
for rat MSCs. Normal human MSCs were purchased from Cambrex Bio Science 
Walkersville, Inc. In the case of CJD patients, informed consent was obtained from the 
patient’s family, and the investigation protocol was approved by the Ethics Committee 
of Nagasaki University Hospital (ID 06012755).  
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Animal TSE models 
To establish a rat TSE model, 10% (w/w) homogenates of a brain taken from a 
Gerstmann-Sträussler-Scheinker syndrome (GSS) patient carrying the P102L mutation 
in PRNP[10] were prepared with sterile PBS. We first inoculated the homogenate into 
Wistar rats (3 weeks old) and NZW mice (4 weeks old). Although all the rats (n=6) 
remained free of any neurological signs and were healthy until 2 years post inoculation, 
the NZW mice developed typical mouse TSE after around 230 days. The mouse brain 
homogenate was then inoculated into Wistar rats, and those rats developed disease at 
about 330 days. Accumulation of PrPSc in the affected brains was confirmed by Western 
blotting (data not shown), and by histology, in which common characteristics of prion 
disease such as spongiform change, neuronal loss, and gliosis were observed, and 
accumulated PrPSc was stained diffusely by 6H4 antibody. The agent isolated was 
designated Nagasaki University-1 isolate (Nu-1). 
Mouse BSE model: Primary infection of a BSE agent isolated from a cow in the UK 
was done using RIII mice (killed at 412 days) and the affected brains were kindly 
provided to us by Dr. Yokoyama (Tsukuba). We then passed this mouse-adapted BSE 
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into ddY mice twice. Mice intracerebrally inoculated with brain homogenate all 
developed disease at around 150 days, with infectivity in the brain reaching around 108.9 
LD50/g. At the third passage, 100 µl of a 10% brain homogenate were inoculated into 
the peritoneal cavity, and samples of bone marrow, spleen and brain were collected 
every 4 weeks. Infected mice showed abnormal gait and other neurological signs at 
around 20 weeks post inoculation and died at 28 wpi. In some experiments, 
mouse-adapted GSS agent, Fukuoka-1 strain[11], was also inoculated into ddY mice. 
Ex vivo infection (Prion infection to the MSC) 
Normal rat MSCs (passage 5) growing in a T25 flask were exposed to 0.2 % of Nu-1 rat 
brain homogenate for 24 h, after which an equal volume of fresh medium was added 
and the incubation was continued for another 48 h. Then, after washing the cells several 
times with PBS, we split the cells at a ratio of 1:3. At every passage, confluent cells 
were lysed and subjected to Western blotting for PrPSc as described below. 
PrPSc detection 
Brain, spleen and lymph node were homogenized at 10% in phosphate buffered saline. 
Total proteins were extracted by mixing with 1% Triton X-100/DOC buffer (1% Triton 
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X-100, 1% Deoxycholic acid, 300 mM NaCl, 50 mM Tris-HCl pH 7.5) and the mixture 
was centrifuged at 500 x g at 4 ºC for 15 min to remove cell debris. The supernatants 
were digested with Proteinase K (20 µg/mg protein, 37 ºC, 30 min) and mixed with 
sodium dodecyl sulfate (SDS) loading buffer (50mM Tris-HCl pH 6.8, containing 5% 
glycerol, 1.6% SDS, and 100mM dithiothreitol) and boiled for 10 min. Confluent cell 
cultures were lysed for 30 min at 4 ºC in 0.5% Triton X-100/DOC buffer (0.5% Triton 
X-100, 0.5% Deoxycholic acid, 150mM NaCl, 50mM Tris-HCl pH7.5). The supernatant 
was collected after a short centrifugation at 10,000 x g, and the total protein 
concentration was measured using the BCA protein assay (Pierce). The protein 
concentration was adjusted to 1.0 mg/ml, and digested with proteinase K (PK) (40 
µg/mg protein, 37 ºC, 30 min), and then PK-resistant and insoluble PrP was 
concentrated by centrifugation at 19,000 x g for 45 minutes at 4 ºC. The pellet was 
dissolved in 1 x SDS loading buffer and boiled for 10 min. 
In the cell samples as well as the tissues samples, PrPSc was detected by Western 
blotting. SDS-polyacrylamide gel electrophoresis (PAGE) was performed using 1.5mm, 
12% acrylamide gels. The proteins were transferred onto an Immobilon-P membrane 
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(Millipore) in transfer buffer containing 20% methanol, and the membrane was blocked 
with 5% nonfat dry milk in TBST (10mM Tris-HCl pH 7.8, 100mM NaCl, 0.1% Tween 
20) for 60 min at room temperature. Blocked membranes were reacted with anti-PrP 
antibodies diluted 1:1000 in 1% nonfat dry milk/TBST overnight at 4 ºC. The 
membranes were then washed 3 times for 5 min in TBST, reacted with horseradish 
peroxidase (HRP)-conjugated secondary antibodies diluted 1:5000 in 1% nonfat dry 
milk/TBST for 60 min at room temperature and washed again 5 times for 5 min in 
TBST. Immunoreactive bands were visualized using an enhanced chemiluminescence 
system (ECL; Amersham Pharmacia Biotech). The anti-PrP polyclonal mouse antiserum 
(SS#28) used has been described previously. The M20 goat antibody to C-terminal PrP 
peptides was purchased from Santa-Cruz Biotech (Santa Cruz, CA)[12]. Horseradish 
peroxidase (HRP)-conjugated anti-goat immunoglobulin G antibodies were purchased 
from Santa-Cruz Biotech. 
Immunohistochemistry 
Tissue samples were fixed in 10% neutral buffered formalin, embedded in paraffin, and 
sectioned into 5 µm slices. The tissue sections were stained with hematoxylin and eosin 
(HE), or subjected to immunological staining of PrP, using the hydrolytic autoclaving 
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and formic acid method prior to incubating with primary antibodies such as SAF32 (SPI 
bio, France) and 6H4 (Prionics AG, Switzerland) overnight, and then the sections were 
reacted with envision polymer horseradish peroxidase (HRP)-conjugated anti-mouse 
immunoglobulin G antibodies (vectastain ABS Kit, Dako Cytomation) for 60 min. 
Immunostaining was visualized by 3, 3’-diaminobenzidine chromogen via a horseradish 
peroxidase reaction. 
Results and discussion 
MSCs have unique characteristics. They grow well ex vivo without transformation and 
are multipotential progenitor cells which can be used for auto-cell transplant therapy8. 
We isolated and subcultured bone marrow cells, and were able to obtain relatively 
uniform cell types from human, rat and bovine samples, but not from those of mouse 
and hamster. (Fig.1a). The rat bone marrow cells grew for more than 2 years (100 
passages), but the human cells stopped dividing at about 15 passages, and the bovine, 
mouse and hamster cells continued to grow for only a few passages. To confirm that the 
cells isolated from rat bone marrow were indeed MSCs, we tried to differentiate them 
into neurons, according to the method described by Dezawa et al[9] (data not shown). 
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To examine the expression of PrPC, MSCs were analyzed by Western blotting. Anti-PrP 
monoclonal antibody (SAF32) raised against N-terminal octapeptide repeats of PrP 
could detect normal PrP in the MSCs from all species (Fig 1b), and its expression on the 
cell surface was also confirmed by immunostaining (Fig 1c). 
Isolated MSCs from uninfected rat bone marrows were subjected to an ex vivo 
transmission study using a rat-adapted GSS strain, Nagasaki isolate (Nu-1). Primary 
cultured rat MSCs (P3) were incubated with 0.2 % brain homogenate and passaged for 
more than 2 years. In the early phase, little or no PrPSc could be detected in the cultured 
MSCs, but with repetition of passages, the amount increased (Fig. 2) and multinuclear 
cells were observed. The ex vivo infected MSCs initially produced only small amounts 
of PrPSc, which increased with passaging, and stable PrPSc production was confirmed 
after 50 passages, suggesting that the infection spread only gradually. A similar 
observation has been reported in mouse neuronal cells[12]. To confirm that the 
MSC/Nu-1 cells were indeed infected with the agent, we inoculated the cell lysates (P25 
and P50) intracerebrally into Wistar rats (4 weeks old). After one year, the rats all 
showed signs such as reflection abnormality, and Western blotting of the brains 
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confirmed the presence of PrPSc (data not shown). These results provide evidence that 
the MSCs express PrPC and are susceptible to TSE agents, and are capable of supporting 
stable infection. 
To elucidate whether or not MSCs can be infected with the TSE agent in vivo, we 
isolated MSCs from terminally sick animals. The MSCs from Nu-1 Wistar rat at 300 dpi 
grew slowly compared with those from young rats, and we were able to detect PrPSc 
(data not shown). In addition, MSCs from terminally sick mice infected with mouse 
adapted BSE or Fukuoka-1 agents were also positive for PrPSc (Fig 3a). Next, we 
inoculated MSCs from four terminal BSE-infected mice into the brains of normal ddY 
mice (five each). After 20 weeks, all exhibited a yellowish pubic region and abnormal 
hind limb reflex, but after that, clinical signs worsened only slowly. After 25 weeks, we 
sacrificed some of the mice and were able to confirm accumulation of abnormal PrP in 
the spleens (Fig 3b, arrows). This result provides evidence that MSCs in vivo do indeed 
carry the agent.  
We next asked how soon the PrPSc could be seen in MSCs from infected mice. After 
intraperitoneal inoculation of 100µl of the BSE mouse 10% brain homogenate, brains, 
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spleens and bone marrows were collected from 4 or 5 animals every 4 weeks. PrPSc was 
first detected in spleen at 4 wpi and in brains at 24 wpi. MSCs from bone marrow were 
isolated and expanded (passaged 3 times) in order to harvest enough cellular proteins, 
and showed weak PrPSc signals at 4 wpi, which disappeared at 8 wpi, and were again 
detected at 16 to 28 wpi. (Fig 3c). This indicates that infection of the MSCs in vivo 
could precede the accumulation of PrPSc in brain. 
PrP is expressed mainly in the brain but also in many other organs, including the 
lymphoreticular system tissues (LRS)[13,14]. Although the role of PrPC in blood cells 
remains to be established, PrPC is known to be expressed by hematopoietic stem cells 
(HSCs)[15], immature and mature T cells, B cells, monocytes and dendritic cells 
(DCs)[16]. CD43+ Gr-1+ granulocyte precursors in bone marrow have also been shown 
to express PrP[17]. When we analyzed murine bone marrow by in situ hybridization, 
PrPC mRNA stained in HSCs but not MSCs (data not shown). Therefore, although we 
cannot exclude the possibility that MSCs start expressing PrP when the cells are 
cultured ex vivo, our data would suggest that MSCs could express PrP and be a 
long-term reservoir for TSE agents in vivo, in which case circulating white blood cells 
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could also become infected by contact with the MSCs. 
To determine whether human MSCs are also susceptible to TSE agents, we examined 
bone marrows obtained at autopsy from two CJD patients. The first case was a 
66-year-old female who had been clinically diagnosed as having sporadic CJD. The 
patient had died 27 months after the onset. An autopsy was held 7 hours after her death, 
and we collected bone marrow from the sternum. Because coagulation of the blood had 
already advanced, we were able to collect only an extremely small amount of bone 
marrow cells and it took about 2 months to grow sufficient MSCs for the experiment. 
One mg of extracted protein was digested and concentrated at 10,000 x g for 1h, then 
subjected to Western blotting for PrPSc using 3F4 antibody. A relatively weak but clear 
signal was seen in this patient’s MSCs (Fig.4a). The second case was a 70 year-old male 
who also had been diagnosed with sporadic CJD. Abnormally elevated signals in the 
brain had been observed during screening with diffusion NMR, at which time the 
patient was free of symptoms. A few months later, he presented with mild dementia and 
neurological abnormalities. As the clinical manifestations progressed, CSF analysis 
showed that 14-3-3 was elevated and CJD was diagnosed. The patient died about a year 
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after the onset. This time, we were able to collect bone marrow immediately after death. 
A good amount of adherent cells was observed in the primary culture dishes, and after 
expanding them we were able to recover the cellular proteins and perform Western 
blotting analysis. PrPSc was detected even in the P1 cell lysate (Fig 4b). These findings 
suggest that the ex vivo expansion of MSCs could be an alternative diagnostic method 
for CJD.  
Hadlow et al. were the first to report that infectivity could be reached at 105 LD50 in the 
bone marrow (whole femur) of Swiss mice infected with a mouse-adapted scrapie strain, 
Chandler isolate[18, 19]. Others, however, subsequently failed to detect PrPSc in bone 
marrow by Western Blotting[20]. Brown et al. inoculated the bone marrow from CJD 
patients into two normal primates, neither of which went on to develop TSE[21]. These 
results might mean that there was little infectivity in the samples used, or accumulation 
of PrPSc and infectivity in bone marrow might depend on either the strain of agent or the 
host species. How real the risk of infectivity is in the bone marrow of CJD patients 
remains to be assessed using sensitive models. At this point, it is too early to state that 
CJD could be transmitted during bone marrow transplantation, as no accidental 
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transmission has been reported to date.  
Because the clinical features of CJD vary, definitive diagnosis relies on typical brain 
pathology and the post mortem detection of the pathological form of prion protein in the 
brain tissue. Protein analysis of the cerebrospinal fluid (CSF) and diffusion NMR are 
useful tools for differential diagnosis of neurodegenerative disorders and contribute to 
the clinical diagnosis of typical CJD[22]. Recently, a method for the amplification of 
abnormal PrP in vitro (PMCA) from biological samples has been developed and has 
great potential for application to clinical practice[23,24], but it still remains to be 
approved for use on human blood samples. The histological examination of brain biopsy 
specimens is currently the only way to confirm the clinical diagnosis of TSE before 
death. Bone marrow biopsy could thus lead to an early definitive diagnosis, enhancing 
the possibility of successful treatment.  
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 Figure legends 
Figure 1. Bone marrow stromal cells express PrPC. a. Phase-contrast pictures of 
human, mouse, and rat MSCs. b. Western blotting shows PrPC expression in 
these cells. All MSCs isolated from different animals were positive for PrPC. c. 
Immunostaining for PrP on rat MSCs. Typical punctuated staining was seen on 
the cell surface.  
Figure 2. Ex vivo transmission of Nu-1 agent on rat MSCs. PrP signals for the 
Proteinase-K resistant form of PrP (PrPSc) were seen in the culture. N: 
uninfected normal control. P: Nu-1 rat brain homogenate sample. Numbers 
indicate times of passages from infection. 
Figure 3. PrPSc was detected in MSC culture from terminally sick animals and 
was infectious. a. MSCs were isolated from mouse-BSE infected and Fukuoka-1 
infected ddY mice. Both cultures were positive for PrPSc. b. Immunostaining for 
PrPSc in spleen obtained from a mouse inoculated with BSE-MSCs, indicating the 
cells were truly carrying infectivity. c. Time-course analysis of PrPSc in 
BSE-inoculated mice. MSCs were isolated from intraperitoneally infected mice 
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and PrPSc was detected. Note that PrPSc was seen in MSCs as early as 16 wpi.  
Figure 4. a. Ex vivo expanded MSCs from CJD patients were positive for PrPSc. a. 
Bone marrow cells were isolated at autopsy of a sporadic CJD patient. After 
expansion of MSCs for a month, Western blotting for human PrP could detect 
PrPSc in the cell lysate. b. MSCs from another sporadic CJD patient. Bone 
marrow was obtained immediately after death. PrPSc was seen in the culture 
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